Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546328 | SCV000636633 | pathogenic | Kabuki syndrome | 2016-07-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal at codon 3919 (p.Gln3919*) of the KMT2D gene. It is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in KMT2D are known to be pathogenic (PMID: 24633898). For these reasons, this variant has been classified as Pathogenic. |